BioNTech May Be the Next Moderna. Even if it Isn't, the Stock Is a Buy.来源:Barrons发布于 2026-11-13BioNTech has multiple catalysts that could generate a rally of 35% for the stock.相关标的:BNTX继续访问返回新闻本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。